Clinical Trial Update: Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This is a Phase 1 trial update for a three-drug combination (ADI-PEG 20, venetoclax, and azacitidine) in adults with acute myeloid leukemia; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• ADI-PEG 20 (pegylated arginine deiminase)
• VIDAZA (AZACITIDINE)
• Venclexta (venetoclax)

Snippet

Sponsor: Polaris Group | Conditions: Acute Myeloid Leukemia, Adult | Phase 1 | Status: ACTIVE_NOT_RECRUITING